🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Despite recent advances in the treatment of Castrate-Resistant Prostate Can...
Status
Completed
Location
Addenbrooke's Hospital, Cambridge University Hospitals Foundation Trust,
Start Date
2016-12
Trial ID
NCT02324998
TNBC is a heterogeneous disease with distinct pathological, genetic, and cl...
Status
Not Yet Recruiting
Location
SLK-Kliniken Heilbronn GmbH, Klinik für Gynäkologie und Geburtshilfe
Start Date
2026-08-30
Trial ID
NCT07178730
The purpose of this research study is to evaluate the effectiveness of usin...
Status
Active Not Recruiting
Location
Indiana University Simon Comprehensive Cancer Center
Start Date
2022-09-02
Trial ID
NCT05366166
Treatments Being Tested
The goal of this phase 2 clinical trial is to learn if the three treatments...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-11-01
Trial ID
NCT06650709
Treatments Being Tested
The goal of this research study is to evaluate the safety and feasibility o...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-05
Trial ID
NCT05774886
Treatments Being Tested
Researchers are looking for new ways to treat types of breast cancer that a...
Status
Recruiting
Location
Banner MD Anderson Cancer Center ( Site 0066)
Start Date
2025-06-30
Trial ID
NCT06966700
Around 15-25% of ovarian cancer (OC) patients carry germ-line mutation in B...
Status
Unknown
Location
Fondazione Policlinico Gemelli IRCCS
Start Date
2019-12-01
Trial ID
NCT04261465
Treatments Being Tested
Researchers want to learn if giving boserolimab (MK-5890) with standard tre...
Status
Withdrawn
Location
Optum Care Cancer Center ( Site 0004)
Start Date
2025-03-26
Trial ID
NCT06829199
This study will test any good and bad effects of combining the study drugs ...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Start Date
2022-01-31
Trial ID
NCT05203445
Treatments Being Tested
Olaparib treatment in patients with germline BRCA1/2 mutations and high ris...
Status
Active Not Recruiting
Location
Research Site
Start Date
2014-04-22
Trial ID
NCT02032823